Predictors of Delayed and Omitted Postoperative Radiotherapy After Laryngectomy for pT4 Laryngeal Cancer - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Factors Influencing the Timing and Administration of Postoperative Radiotherapy Following Laryngectomy for pT4 Laryngeal Carcinoma

  • By

  • George Ashji

  • Arun Rajan

  • Elias Dahl

  • Sudarshan Ramanan

  • Nishant Chadha

  • Yingzhi Wu

  • Richard J. Wong

  • Marc A. Cohen

  • Edward Christopher Dee

  • Nancy Y. Lee

  • September 21, 2026

Share

Objective:

To examine the clinical relevance of the 42-day postoperative radiotherapy (PORT) benchmark and identify factors associated with delayed or omitted treatment in adults with nonmetastatic pT4 laryngeal squamous cell carcinoma treated by total laryngectomy.

Approach:
  • Study Design: A retrospective cohort analysis using National Cancer Database (NCDB) data from January 1, 2010, to December 31, 2022.
  • Study Population: Adults aged ≥18 years with invasive, nonmetastatic laryngeal SCC who underwent total laryngectomy, radical laryngectomy, or pharyngolaryngectomy.
  • Outcomes and Measures: The interval from surgery to PORT was measured, with benchmark failure defined as PORT initiation more than 42 days postoperatively.
  • Statistical Analysis: Multivariable logistic regression was used to evaluate factors associated with failure to meet the PORT benchmark.
Key Findings:
  • Approximately 49% of patients with HNSCC in the U.S. started PORT more than 6 weeks after surgery, according to a meta-analysis.
  • The mean time-to-PORT was nearly 47 days, as reported in the literature.
  • Delays in PORT initiation were attributed to various socioeconomic and clinical factors, as noted in previous studies.
Interpretation:

The study examines the challenges in achieving timely PORT following total laryngectomy, highlighting the need for procedure-specific evaluations.

Limitations:
  • The study is limited to data from the NCDB, which may not capture all relevant clinical factors.
  • Findings may not be generalizable to all head and neck cancer patients due to the focus on laryngeal carcinoma.
Conclusion:

Understanding factors influencing PORT timing is crucial for improving treatment processes for patients with pT4 laryngeal carcinoma.

Sources:

Original Source(s)

Related Content